A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with severe depression, the FDA says. Here's what that means.

The FDA approving a new non-opioid painkiller, meaning it does not carry the risk of addiction.

Readers and medical professionals discuss the Trump administration halting communication and travel at HHS. Regarding the Jan ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

The problem ingredient identified was "undeclared milk," which poses a risk to those with severe sensitivities or allergies.

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.

The FDA is overhauling food labels to redefine "'healthy," focusing on redefining terms and introducing new front-of-package ...